MILLENNIUM MANAGEMENT LLC - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 63 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$10,559,402
+40805.7%
382,310
-65.9%
0.01%
-66.7%
Q1 2023$25,814
+69.6%
1,122,342
-19.6%
0.02%
+87.5%
Q4 2022$15,224
-99.1%
1,395,389
+604.7%
0.01%
+700.0%
Q3 2022$1,669,000
-81.2%
198,022
-82.3%
0.00%
-80.0%
Q2 2022$8,855,000
-23.7%
1,119,528
+128.4%
0.01%
-16.7%
Q1 2022$11,606,000
-19.4%
490,115
+16.4%
0.01%
-14.3%
Q4 2021$14,401,000
+39.4%
421,073
-27.8%
0.01%0.0%
Q3 2021$10,328,000
+1390.3%
582,871
+3675.1%
0.01%
Q2 2021$693,000
+145.7%
15,440
+41.8%
0.00%
Q1 2021$282,000
-38.6%
10,892
-52.2%
0.00%
Q4 2020$459,000
-93.2%
22,766
-94.1%
0.00%
-100.0%
Q2 2020$6,785,000
+180.8%
384,205
+12.3%
0.01%
+80.0%
Q1 2020$2,416,000
-59.5%
342,175
-59.6%
0.01%
-28.6%
Q4 2019$5,971,000
-40.7%
846,994
+1.1%
0.01%
-56.2%
Q3 2019$10,063,000
+2.5%
837,892
+3.3%
0.02%
+6.7%
Q2 2019$9,822,000
-12.5%
811,066
-9.2%
0.02%
-11.8%
Q1 2019$11,227,000
+141.7%
893,155
+29.4%
0.02%
+142.9%
Q4 2018$4,645,000
-56.3%
690,151
-33.2%
0.01%
-46.2%
Q3 2018$10,638,000
+593.5%
1,033,798
+352.9%
0.01%
+550.0%
Q2 2018$1,534,000
-44.3%
228,281
-28.8%
0.00%
-50.0%
Q1 2018$2,755,000
-31.3%
320,739
+66.4%
0.00%
-33.3%
Q4 2017$4,009,000
+65.2%
192,730
+40.3%
0.01%
+50.0%
Q3 2017$2,427,000
+6.4%
137,352
-31.9%
0.00%0.0%
Q2 2017$2,281,000201,7120.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$67,646,43421.00%
COWEN AND COMPANY, LLC 1,657,551$45,781,5583.80%
Kynam Capital Management, LP 975,298$26,937,7313.70%
BVF INC/IL 3,775,900$104,290,3582.91%
RTW INVESTMENTS, LP 5,415,514$149,576,4972.85%
Cormorant Asset Management, LP 1,500,000$41,430,0002.32%
Ghost Tree Capital, LLC 225,000$6,214,5002.05%
683 Capital Management, LLC 814,000$22,482,6801.62%
Perceptive Advisors 1,469,761$40,594,7991.18%
Artia Global Partners LP 112,340$3,102,8311.07%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders